Cyclezyme reported no revenue and increased losses in H1 2024 but achieved a major breakthrough in enzymatic PET recycling, positioning itself for future commercialization. Strong liquidity supports ongoing R&D and strategic partnerships.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.